[{"AccountsPayableCurrent_0_Q3_USD":4614000.0,"OtherNonoperatingIncome_3_Q3_USD":100000000.0,"OtherLongTermInvestments_0_Q3_USD":10533000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-107000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":754000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1598000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":588000.0,"OperatingLeaseLiability_0_Q3_USD":2692000.0,"OperatingIncomeLoss_3_Q3_USD":-119070000.0,"OperatingIncomeLoss_1_Q3_USD":-44240000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":366000.0,"NonoperatingIncomeExpense_3_Q3_USD":100313000.0,"NetIncomeLoss_3_Q3_USD":-26746000.0,"NetIncomeLoss_1_Q3_USD":-35107000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-105531000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-69407000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":166381000.0,"LiabilitiesCurrent_0_Q3_USD":23467000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":355823000.0,"Liabilities_0_Q3_USD":33560000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":516000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":203000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":834000.0,"NonoperatingIncomeExpense_1_Q3_USD":138000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":851000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":456238000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":180000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":233000.0,"StockholdersEquity_0_Q3_USD":322263000.0,"ShortTermInvestments_0_Q3_USD":235982000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_3_Q3_USD":2811000.0,"ShareBasedCompensation_3_Q3_USD":16128000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":47490000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":17507000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":1337000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":1028000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-486073000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"RestrictedCash_0_Q3_USD":328000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":27539000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2956000.0,"ProfitLoss_3_Q3_USD":-26746000.0,"ProceedsFromStockPlans_3_Q3_USD":621000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":4029000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":292197000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":161731000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7282000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":72554000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":502000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":818000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3208000.0,"CommonStockSharesOutstanding_0_Q3_shares":50268312.0,"CommonStockSharesIssued_0_Q3_shares":50268312.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-8557000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":92700000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":328354000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":92372000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":235982000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":235961000.0,"CommonStockValue_0_Q3_USD":50000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":8000.0,"AssetsCurrent_0_Q3_USD":335636000.0,"Assets_0_Q3_USD":355823000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6406621.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6406621.0,"AmortizationOfIntangibleAssets_3_Q3_USD":228000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":114000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5268000.0,"AdditionalPaidInCapital_0_Q3_USD":808265000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":21000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2560000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":18265000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":29000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-35107000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-26853000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":222000.0,"LesseeOperatingLeaseDiscountRate_0_Q3_pure":0.1,"InvestmentIncomeInterest_3_Q3_USD":313000.0,"InvestmentIncomeInterest_1_Q3_USD":138000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1591000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":10533000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":5392000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":7989000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-8995000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-18757000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-44102000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":4772000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":455000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":455000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":455000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":114000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":455000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":2104000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.54,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.7,"DepreciationDepletionAndAmortization_3_Q3_USD":833000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":7989000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":7989000.0,"CostsAndExpenses_3_Q3_USD":120407000.0,"CostsAndExpenses_1_Q3_USD":45268000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":363000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":50246303.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":49374336.0,"Ticker":"RYTM","CIK":"1649904","name":"RHYTHM PHARMACEUTICALS, INC.","OfficialName":"Rhythm Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"415723429.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211102"}]